Foxboro, MA, United States of America

Steven Wayne Jilcott, Jr

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Steven Wayne Jilcott, Jr.

Introduction

Steven Wayne Jilcott, Jr. is an accomplished inventor based in Foxboro, MA (US). He has made significant contributions to the field of biotechnology, particularly in the identification of malicious organic sequences. His innovative approach has the potential to enhance the safety and security of biological research.

Latest Patents

Jilcott holds a patent for a method titled "Identifying signature snippets for nucleic acid sequence types." This patent describes a process for identifying regions of malicious organic sequences by comparing them to benign snippets derived from non-threatening organisms. The method involves extracting candidate signature snippets from sequences obtained from malicious organisms and determining their match with benign snippets. If a candidate snippet does not match any benign snippets, it is identified as a malicious signature snippet. This innovative technique is crucial for advancing biosecurity measures.

Career Highlights

Steven Jilcott is currently employed at Raytheon BBN Technologies Corporation, where he applies his expertise in biotechnology and bioinformatics. His work focuses on developing methods that enhance the understanding of genetic sequences and their implications for safety in biological research.

Collaborations

Jilcott collaborates with notable colleagues, including Jacob Stuart Michael Beal and Daniel Wyschogrod. These partnerships foster a dynamic environment for innovation and research, contributing to advancements in their respective fields.

Conclusion

Steven Wayne Jilcott, Jr. exemplifies the spirit of innovation in biotechnology through his patented methods and collaborative efforts. His work not only addresses current challenges in biosecurity but also paves the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…